Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodixanol vs Iopromide Nephrotoxicity in Renal Insufficiency
NCT00823628Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Feb 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iodixanol in coronary heart disease (CHD), sponsored by Seoul National University Bundang Hospital. Started Feb 2009; status: completed.
02
Drugs
iodixanol
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00823628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00823628.